Rare side effects may include some redness at the injection site, mild nausea, or light-headedness
In some types, it makes the connective tissue of blood vessels and organs weakened, making them more prone to rupture
Semaglutide and tirzepatide have their marketing authorizations, but neither is reimbursed in France for obesity as of May 2026, despite favorable opinions from the French National Authority for Health (HAS)
Still, there are higher chances that you will only need one medicine per day
liraglutide provides shorter, more frequent increases that some people may like for managing their dose
However, phase 1 clinical trials in patients with locally advanced non-small cell lung cancer and pancreatic cancer showed suboptimal compliance with the diet, indicating challenges in practical application